4-(4-Aminophenoxy)-N-Methylpicolinamide CAS 284462-37-9 Sorafenib Tosylate Waena Hana Hana Ma'ema'e Ki'eki'e
Hāʻawi Kūʻai ʻo Sorafenib Tosylate a me nā mea waena e pili ana:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
| Inoa Kimia | 4-(4-Aminophenoxy)-N-Methylpicolinamide |
| Nā huaʻōlelo like | 4-(4-Aminophenoxy)-N-Methyl-2-Pyridinecarboxamide |
| Helu CAS | 284462-37-9 |
| Helu CAT | RF-PI166 |
| Kūlana Kūʻai | Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā tona |
| ʻĀpana Molekala | C13H13N3O2 |
| Kaumaha Molecular | 243.27 |
| Lae hehee | 110.0~112.0 ℃ |
| ʻO ka mānoanoa | 1.241 g/cm3 |
| Brand | ʻO Ruifu Chemical |
| 'ikamu | Nā kikoʻī |
| Ka nana aku | ʻAlaʻulaʻulaʻulaʻulaʻulaʻulaʻulaʻulaʻulaʻulaʻulaʻula a hiki i ka pauda keʻokeʻo |
| Maʻemaʻe / Kaʻina Hanana | 98.0%~101.0% (ma ke kumu maloʻo) (HPLC) |
| Nalo ma ka maloo | ≤0.50% |
| Koena ma ka Ignition | ≤0.20% |
| Hoʻokahi haumia | ≤0.20% |
| Huina haumia | ≤1.0% |
| Metala Kaumaha | ≤20ppm |
| Kūlana hoʻāʻo | ʻOihana Kūlana |
| Hoʻohana | Ka waena o Sorafenib Tosylate (CAS: 475207-59-1) |
Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.
Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.
Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Hāʻawi Kalepa Sorafenib Tosylate (CAS: 475207-59-1) Nā Kūwaena Pili:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
ʻO Sorafenib Tosylate (CAS: 475207-59-1) kahi ʻano hou o ka lāʻau antitumor multi-target, i hoʻomohala ʻia e ka German Bayer Pharmaceuticals, a hōʻike i ka hana antitumor expansive i nā hoʻokolohua holoholona preclinical.Loaʻa ka Sorafenib i nā papa 200-mg no ka hoʻokele waha a hoʻohana ʻia i ka mālama ʻana o RCC a me HCC.
